NCT00624533 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kovacs FM, Abraira V, Zamora J, Teresa Gil del Real M, Llobera J, Fernández C, Bauza JR, Bauza K, Coll J, Cuadri M, Duro E, Gili J, Gestoso M, Gómez M, González J, Ibañez P, Jover A, Lázaro P, Llinás M, Mateu C, Mufraggi N, Muriel A, Nicolau C, Olivera MA, Pascual P, Perelló L, Pozo F, Revuelta T, Reyes V, Ribot S, Ripoll J, Ripoll J, Rodríguez E; Kovacs-Atención Primaria Group
Correlation between pain, disability, and quality of life in patients with common low back pain. Spine (Phila Pa 1976). 2004 Jan 15;29(2):206-10.

Evaluation of the Efficiency of Physiotherapeutic Treatment of Non-Specific Low Back Pain in Primary Care Centers Through GDS Techniques for Articular and Muscular Chains

Details for clinical trial NCT00624533

Clinical trial NCT00624533 - References